Adicet Bio, Inc. (TORC) SEC Filing 8-K Material Event for the period ending Tuesday, September 15, 2020

Restorbio, Inc.

CIK: 1720580 Ticker: TORC

View differences made from one to another to evaluate Restorbio, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Restorbio, Inc..


Assess how Restorbio, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Restorbio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Restorbio, Inc. provided additional information to their SEC Filing as exhibits

Ticker: TORC
CIK: 1720580
Form Type: 8-K Corporate News
Accession Number: 0001193125-20-245865
Submitted to the SEC: Tue Sep 15 2020 9:09:01 AM EST
Accepted by the SEC: Tue Sep 15 2020
Period: Tuesday, September 15, 2020
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: